Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells

Gina Chun Kost, Senthil Selvaraj, Young Bok Lee, Deog Joong Kim, Chang Ho Ahn, Brij B. Singh

Research output: Contribution to journalArticle

15 Citations (Scopus)

Abstract

Clavulanic acid is a psychoactive compound that has been shown to modulate central nervous system activity. Importantly, in neurotoxin-induced animal models, clavulanic acid has been shown to improve motor function (Huh et al., 2010) suggesting that it can be neuroprotective; however, the mechanism as how clavulanic acid can induce neuroprotection is not known. We demonstrate here that clavulanic acid abrogates the effects of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) which mimics Parkinson's disease (PD) by inducing neurodegeneration. To further establish the mechanism we identified that clavulanic acid inhibits neurotoxin-induced loss of mitochondrial membrane potential and ROS production. Consistent with these results, neurotoxin-induced increase in Bax levels was also decreased in clavulanic acid treated cells. Importantly, neurotoxin-induced release of cytochrome c levels as well as caspase activation was also inhibited in clavulanic acid treated cells. In addition, Bcl-xl levels were also restored and the Bcl-xl/Bax ratio that is critical for inducing apoptosis was increased in clavulanic acid treated cells. Overall, these results suggest that clavulanic acid is intimately involved in inhibiting neurotoxin-induced loss of mitochondrial function and induction of apoptosis that contributes towards neuronal survival.

Original languageEnglish
Pages (from-to)129-135
Number of pages7
JournalBrain Research
Volume1469
DOIs
Publication statusPublished - 21 Aug 2012
Externally publishedYes

Fingerprint

Clavulanic Acid
Neurotoxins
1-Methyl-4-phenylpyridinium
Apoptosis
Mitochondrial Membrane Potential
Caspases
Cytochromes c
Parkinson Disease
Central Nervous System
Animal Models

Keywords

  • Apoptosis
  • Clavulanic acid
  • Mitochondria
  • MPTP
  • Neuroprotection
  • Parkinson's disease (PD)

ASJC Scopus subject areas

  • Neuroscience(all)
  • Clinical Neurology
  • Developmental Biology
  • Molecular Biology

Cite this

Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells. / Kost, Gina Chun; Selvaraj, Senthil; Lee, Young Bok; Kim, Deog Joong; Ahn, Chang Ho; Singh, Brij B.

In: Brain Research, Vol. 1469, 21.08.2012, p. 129-135.

Research output: Contribution to journalArticle

Kost, Gina Chun ; Selvaraj, Senthil ; Lee, Young Bok ; Kim, Deog Joong ; Ahn, Chang Ho ; Singh, Brij B. / Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells. In: Brain Research. 2012 ; Vol. 1469. pp. 129-135.
@article{d73331724d2849949164ec028819b2af,
title = "Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells",
abstract = "Clavulanic acid is a psychoactive compound that has been shown to modulate central nervous system activity. Importantly, in neurotoxin-induced animal models, clavulanic acid has been shown to improve motor function (Huh et al., 2010) suggesting that it can be neuroprotective; however, the mechanism as how clavulanic acid can induce neuroprotection is not known. We demonstrate here that clavulanic acid abrogates the effects of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) which mimics Parkinson's disease (PD) by inducing neurodegeneration. To further establish the mechanism we identified that clavulanic acid inhibits neurotoxin-induced loss of mitochondrial membrane potential and ROS production. Consistent with these results, neurotoxin-induced increase in Bax levels was also decreased in clavulanic acid treated cells. Importantly, neurotoxin-induced release of cytochrome c levels as well as caspase activation was also inhibited in clavulanic acid treated cells. In addition, Bcl-xl levels were also restored and the Bcl-xl/Bax ratio that is critical for inducing apoptosis was increased in clavulanic acid treated cells. Overall, these results suggest that clavulanic acid is intimately involved in inhibiting neurotoxin-induced loss of mitochondrial function and induction of apoptosis that contributes towards neuronal survival.",
keywords = "Apoptosis, Clavulanic acid, Mitochondria, MPTP, Neuroprotection, Parkinson's disease (PD)",
author = "Kost, {Gina Chun} and Senthil Selvaraj and Lee, {Young Bok} and Kim, {Deog Joong} and Ahn, {Chang Ho} and Singh, {Brij B.}",
year = "2012",
month = "8",
day = "21",
doi = "10.1016/j.brainres.2012.06.005",
language = "English",
volume = "1469",
pages = "129--135",
journal = "Brain Research",
issn = "0006-8993",
publisher = "Elsevier",

}

TY - JOUR

T1 - Clavulanic acid inhibits MPP+-induced ROS generation and subsequent loss of dopaminergic cells

AU - Kost, Gina Chun

AU - Selvaraj, Senthil

AU - Lee, Young Bok

AU - Kim, Deog Joong

AU - Ahn, Chang Ho

AU - Singh, Brij B.

PY - 2012/8/21

Y1 - 2012/8/21

N2 - Clavulanic acid is a psychoactive compound that has been shown to modulate central nervous system activity. Importantly, in neurotoxin-induced animal models, clavulanic acid has been shown to improve motor function (Huh et al., 2010) suggesting that it can be neuroprotective; however, the mechanism as how clavulanic acid can induce neuroprotection is not known. We demonstrate here that clavulanic acid abrogates the effects of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) which mimics Parkinson's disease (PD) by inducing neurodegeneration. To further establish the mechanism we identified that clavulanic acid inhibits neurotoxin-induced loss of mitochondrial membrane potential and ROS production. Consistent with these results, neurotoxin-induced increase in Bax levels was also decreased in clavulanic acid treated cells. Importantly, neurotoxin-induced release of cytochrome c levels as well as caspase activation was also inhibited in clavulanic acid treated cells. In addition, Bcl-xl levels were also restored and the Bcl-xl/Bax ratio that is critical for inducing apoptosis was increased in clavulanic acid treated cells. Overall, these results suggest that clavulanic acid is intimately involved in inhibiting neurotoxin-induced loss of mitochondrial function and induction of apoptosis that contributes towards neuronal survival.

AB - Clavulanic acid is a psychoactive compound that has been shown to modulate central nervous system activity. Importantly, in neurotoxin-induced animal models, clavulanic acid has been shown to improve motor function (Huh et al., 2010) suggesting that it can be neuroprotective; however, the mechanism as how clavulanic acid can induce neuroprotection is not known. We demonstrate here that clavulanic acid abrogates the effects of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) which mimics Parkinson's disease (PD) by inducing neurodegeneration. To further establish the mechanism we identified that clavulanic acid inhibits neurotoxin-induced loss of mitochondrial membrane potential and ROS production. Consistent with these results, neurotoxin-induced increase in Bax levels was also decreased in clavulanic acid treated cells. Importantly, neurotoxin-induced release of cytochrome c levels as well as caspase activation was also inhibited in clavulanic acid treated cells. In addition, Bcl-xl levels were also restored and the Bcl-xl/Bax ratio that is critical for inducing apoptosis was increased in clavulanic acid treated cells. Overall, these results suggest that clavulanic acid is intimately involved in inhibiting neurotoxin-induced loss of mitochondrial function and induction of apoptosis that contributes towards neuronal survival.

KW - Apoptosis

KW - Clavulanic acid

KW - Mitochondria

KW - MPTP

KW - Neuroprotection

KW - Parkinson's disease (PD)

UR - http://www.scopus.com/inward/record.url?scp=84864756380&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864756380&partnerID=8YFLogxK

U2 - 10.1016/j.brainres.2012.06.005

DO - 10.1016/j.brainres.2012.06.005

M3 - Article

VL - 1469

SP - 129

EP - 135

JO - Brain Research

JF - Brain Research

SN - 0006-8993

ER -